GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AMED Co Ltd (ROCO:7575) » Definitions » Return-on-Tangible-Asset

AMED Co (ROCO:7575) Return-on-Tangible-Asset : 9.43% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is AMED Co Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. AMED Co's annualized Net Income for the quarter that ended in Jun. 2024 was NT$82.0 Mil. AMED Co's average total tangible assets for the quarter that ended in Jun. 2024 was NT$869.8 Mil. Therefore, AMED Co's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2024 was 9.43%.

The historical rank and industry rank for AMED Co's Return-on-Tangible-Asset or its related term are showing as below:

ROCO:7575' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.1   Med: 8.7   Max: 11.88
Current: 11.77

During the past 5 years, AMED Co's highest Return-on-Tangible-Asset was 11.88%. The lowest was 5.10%. And the median was 8.70%.

ROCO:7575's Return-on-Tangible-Asset is ranked better than
87.61% of 872 companies
in the Medical Devices & Instruments industry
Industry Median: -2.18 vs ROCO:7575: 11.77

AMED Co Return-on-Tangible-Asset Historical Data

The historical data trend for AMED Co's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AMED Co Return-on-Tangible-Asset Chart

AMED Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
5.10 7.54 8.70 11.28 11.88

AMED Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.74 14.05 9.79 14.56 9.43

Competitive Comparison of AMED Co's Return-on-Tangible-Asset

For the Medical Instruments & Supplies subindustry, AMED Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AMED Co's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where AMED Co's Return-on-Tangible-Asset falls into.



AMED Co Return-on-Tangible-Asset Calculation

AMED Co's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=91.716/( (737.345+806.16)/ 2 )
=91.716/771.7525
=11.88 %

AMED Co's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=81.986/( (806.16+933.526)/ 2 )
=81.986/869.843
=9.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data.


AMED Co  (ROCO:7575) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


AMED Co Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of AMED Co's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


AMED Co Business Description

Traded in Other Exchanges
N/A
Address
No. 14, Wuquan 7th Road, 4th Floor, Wugu District, New Taipei, TWN
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.

AMED Co Headlines

No Headlines